Marché mondial des stylos pour diabétiques – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché des stylos pour diabétiques

L'augmentation de la population de patients diabétiques à travers le monde est l'un des facteurs importants qui devraient intensifier la croissance et la demande du marché des stylos pour diabétiques. En outre, la forte demande d'analogues de l'insuline humaine et l'augmentation de l'incidence des blessures par piqûre d'aiguille devraient également contribuer à la croissance du marché. En outre, le remboursement de la gestion du diabète et les progrès technologiques rapides dans la production de stylos pour diabétiques sont également susceptibles de favoriser la croissance du marché. En outre, l'augmentation des traitements particuliers contre le cancer ainsi que l'accès facile à une grande partie des médicaments font également partie des facteurs importants qui devraient alimenter la croissance du marché des stylos pour diabétiques.

Data Bridge Market Research analyse que le marché mondial des stylos pour diabétiques, qui était de 10,13 milliards USD en 2023, devrait atteindre 22,99 milliards USD d'ici 2031 et devrait connaître un TCAC de 8,9 % au cours de la période de prévision. La « pharmacie de détail » domine le segment des canaux de distribution du marché. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché

Market Definition

The diabetes pens are largely used to inject insulin for the treatment of diabetes. It is basically composed of an insulin cartridge, which is incorporated or bought separately, and a dial to quantify the dose, and is also used with disposable pen needles to deliver the dose.

Global Diabetes Pen Market Dynamics

Drivers

• Growing Prevalence of Diabetes

The increasing global incidence of diabetes is a major driver for the diabetes pen market. As more individuals are diagnosed with diabetes, the demand for convenient and effective insulin delivery devices like diabetes pens is on the rise.

• Advancements in Diagnostic Technologies

Ongoing advancements in diabetes pen technologies, such as the development of smart insulin pens and connected devices, are enhancing user experience and adherence to insulin therapy. These innovations contribute to market growth.

• Patient Preference for Non-invasive Delivery

Patients often prefer non-invasive and user-friendly insulin delivery options. Diabetes pens offer a less invasive alternative to traditional insulin syringes, driving their adoption among patients.

 Opportunities

• Increasing Awareness and Education

Opportunities lie in increasing awareness about the benefits of diabetes pens and providing education to healthcare professionals and patients. This can enhance acceptance and adoption.

• Focus on Emerging Markets

There is significant growth potential in emerging markets where diabetes prevalence is rising. Manufacturers can explore opportunities in these regions by offering cost-effective and user-friendly diabetes pen solutions.

Restraints

• High Cost of Smart Insulin Pens

While smart insulin pens offer advanced features such as dose tracking and connectivity, they can be expensive. The high cost of these devices can limit their adoption, particularly in regions with budget constraints.

• Limited Adoption in Developing Regions

Access to advanced healthcare technologies, including diabetes pens, may be limited in developing regions due to economic constraints and inadequate healthcare infrastructure.

Global Diabetes Pen Market Scope

The diabetes pen market is segmented on the basis of product type, usage, application and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product type

•  Insulin Pens
• Insulin Pen Needle.

Usage

• Reusable Pens
• Disposable Pens

Application

• Type 1 Diabetes
•  Type 2 Diabetes

Distribution Channel

• Hospital Pharmacy
•  Retail Pharmacy
• Online Sales
• Diabetes Clinics.

Diabetes Pen Market Regional Analysis/Insights

The diabetes pen market is analyzed and market size insights and trends are provided by country, product type, usage, application and distribution channel as referenced above.

The countries covered in the market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Kuwait, Egypt, and rest of Middle East & Africa.

North America is expected to dominate the market due to the rise in the diabetic population and better awareness and reimbursement policy for diabetes management.

Asia-Pacific is expected to show the fastest growth due to surging government initiatives to spread awareness and increase the geriatric population in this region. Also, the development of healthcare infrastructure will further propel the market's growth rate in this region.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Healthcare Infrastructure growth Installed base and New Technology Penetration

The diabetes pen market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for diabetes pen market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on diabetes pen market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Diabetes Pen Market Share Analysis

Le paysage concurrentiel du marché des stylos pour diabétiques fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des stylos pour diabétiques.

Certains des principaux acteurs opérant sur le marché des stylos pour diabétiques sont :

• AstraZeneca (Royaume-Uni)
• BD (États-Unis)
• Eli Lilly and Company (États-Unis)
• Biocon (Inde)
• Sanofi (France)
• Jiangsu Delfu Medical Device Co., Ltd. (Chine)
• Owen Mumford (Royaume-Uni)
• Wockhardt Limited (Inde) (Inde)
• Smiths Group plc (Royaume-Uni)
• Sociétés du groupe Nipro Europe (Pays-Bas)
• Novo Nordisk India Pvt Ltd. (Inde)
• InjexUK (Royaume-Uni)
• MannKind Corporation (États-Unis)
• Société Bristol-Myers Squibb (États-Unis)
• F. Hoffmann-La Roche SA (Suisse)
• Copernic (Pologne)
• Ypsomed AG (Suisse)
• HTL-STREFA SA (Pologne)
• Merck & Co., Inc. (États-Unis)
• Bayer AG (Allemagne)

SKU-13857